Status:
UNKNOWN
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Pancreas Neoplasms
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the diagnosis accuracy of 22G EUS Procore fine needle biopsy （FNB）device and 20G EUS Procore fine needle biopsy device for solid pancreatic lesions.
Detailed Description
This is a single-blind, randomized, controlled trial. One thousand two hundred and twenty four patients with solid pancreatic lesions referred for EUS guided fine needle biopsy will be randomly assign...
Eligibility Criteria
Inclusion
- Age \>18 years old,\<85 years old;
- Gender: Male or Female;
- Presence solid occupying pancreatic lesions (the diameter\>1cm);
- Must be able to receive examinations in the research center;
- Must be able to sign the informed consent.
Exclusion
- Hemoglobin≤8.0 g/dl;
- Pregnant women;
- Coagulation disorders;
- Took anticoagulants such as aspirin, warfarin in the latest week;
- Acute pancreatitis in the past two weeks;
- Cardiopulmonary dysfunction;
- Cannot sign the informed consent
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
1224 Patients enrolled
Trial Details
Trial ID
NCT03803930
Start Date
March 1 2019
End Date
August 1 2020
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bin Cheng
Wuhan, Hubei, China, 430030